title: [Antiandrogen withdrawal syndrome in hormone refractory metastatic prostate cancer].
authors.forename: G
authors.initials: G
authors.lastname: Coutant
authors.forename: J P
authors.initials: JP
authors.lastname: Algayres
authors.forename: M L
authors.initials: ML
authors.lastname: Dordain
authors.forename: F
authors.initials: F
authors.lastname: Selle
authors.forename: P Y
authors.initials: PY
authors.lastname: Le Berruyer
authors.forename: H
authors.initials: H
authors.lastname: Bili
authors.forename: J P
authors.initials: JP
authors.lastname: Daly
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy / Q000473:pathology* / Q000556:secondary; D000368:Aged; D000726:Androgen Antagonists / Q000009:adverse effects*; D001859:Bone Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000556:secondary*; D006801:Humans; D008297:Male; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000097:blood / Q000188:drug therapy* / Q000473:pathology; D013375:Substance Withdrawal Syndrome
chemical_list: D000726:Androgen Antagonists; D017430:Prostate-Specific Antigen